Patents by Inventor Jens Kaufmann

Jens Kaufmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11969484
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Grant
    Filed: June 20, 2019
    Date of Patent: April 30, 2024
    Assignee: Ariceum Therapeutics GmbH
    Inventors: Marie Delporte, Sabine Hovest, Jens Kaufmann, Dennis Mewis, Anne Petit, Joel Richard
  • Publication number: 20230181771
    Abstract: The present invention relates to a somatostatin analogue composition for radiopharmaceutical use, in particular for diagnostic or therapeutic use. More specifically the somatostatin analogue is a receptor-selective somatostatin peptide antagonist.
    Type: Application
    Filed: June 20, 2019
    Publication date: June 15, 2023
    Inventors: Marie Delporte, Sabine Hovest, Jens Kaufmann, Dennis Mewis, Anne Petit, Joel Richard
  • Patent number: 10476281
    Abstract: The invention relates to a redox flow battery system, comprising a controller and a battery inverter, which is suitable for charging and/or discharging a battery. The battery inverter comprises: a) a plurality of battery connections, to each of which at least one battery can be connected; b) a first measuring device, which is suitable for measuring the voltage at a battery connection and which is connected to the controller with regard to signaling; c) a second measuring device, which is suitable for measuring the current at a battery connection and which is connected to the controller with regard to signaling; d) a grid connection, which can be connected to an alternating-current supply grid; and e) a plurality of DC/DC converters, of which at least one has a first bridge circuit directly connected to a battery connection.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: November 12, 2019
    Assignee: TRUMPF Huettinger GmbH + Co. KG
    Inventors: Jens Kaufmann, Thomas Lueth
  • Publication number: 20180109123
    Abstract: The invention relates to a redox flow battery system, comprising a controller and a battery inverter, which is suitable for charging and/or discharging a battery. The battery inverter comprises: a) a plurality of battery connections, to each of which at least one battery can be connected; b) a first measuring device, which is suitable for measuring the voltage at a battery connection and which is connected to the controller with regard to signaling; c) a second measuring device, which is suitable for measuring the current at a battery connection and which is connected to the controller with regard to signaling; d) a grid connection, which can be connected to an alternating-current supply grid; and e) a plurality of DC/DC converters, of which at least one has a first bridge circuit directly connected to a battery connection.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 19, 2018
    Inventors: Jens Kaufmann, Thomas Lueth
  • Patent number: 8357705
    Abstract: The invention relates to compounds that have an affinity to the ?-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain or other conditions.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: January 22, 2013
    Assignee: Gruenenthal GmbH
    Inventors: Saskia Zemolka, Bert Nolte, Klaus Linz, Derek John Saunders, Wolfgang Schröder, Werner Englberger, Fritz Theil, Hans Schick, Jens Kaufmann, Julian Gebauer, Helmut Sonnenschein
  • Publication number: 20090247591
    Abstract: The invention relates to compounds that have an affinity to the ?-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain or other conditions.
    Type: Application
    Filed: March 25, 2009
    Publication date: October 1, 2009
    Applicant: Grunenthal GmbH
    Inventors: Saskia Zemolka, Bert Nolte, Klaus Linz, Derek John Saunders, Wolfgang Schroder, Wemer Englberger, Fritz Theil, Hans Schick, Jens Kaufmann, Julian Gebauer, Helmut Sonnenschein